Docetaxel-based CRT improves survival in cisplatin-ineligible patients

Nature Reviews Clinical Oncology, Published online: 10 February 2023; doi:10.1038/s41571-023-00740-7Docetaxel-based CRT improves survival in cisplatin-ineligible patients

https://www.nature.com/articles/s41571-023-00740-7

Source: Nature Reviews Clinical Oncology - February 10, 2023 Category: Cancer & Oncology Authors: David Killock Source Type: research

More News: Cancer & Oncology | Docetaxel | Taxotere